Yong-Jun Wang Selected Research

Osteoporotic Fractures

3/2024	Multi-modal molecular determinants of clinically relevant osteoporosis subtypes.
11/2019	Polymorphisms of genes related to vitamin D metabolism and transportation and its relationship with the risk of osteoporosis: protocol for a multicentre prospective cohort study in China.
1/2016	Biomechanical Characteristics of Osteoporotic Fracture Healing in Ovariectomized Rats: A Systematic Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Jun Wang Research Topics

Disease

47	Stroke (Strokes) 11/2023 - 10/2008
30	Ischemic Stroke 11/2023 - 05/2009
12	Pain (Aches) 01/2022 - 01/2010
11	Inflammation (Inflammations) 11/2023 - 02/2009
10	Spinal Cord Injuries (Spinal Cord Injury) 09/2023 - 02/2016
8	Osteoporosis 03/2024 - 06/2010
8	Transient Ischemic Attack 10/2021 - 10/2008
7	Neuroinflammatory Diseases 09/2023 - 01/2019
7	Neck Pain (Cervicalgia) 01/2022 - 01/2010
6	Intervertebral Disc Degeneration 03/2023 - 02/2007
6	Hypertension (High Blood Pressure) 02/2023 - 12/2008
6	Atrial Fibrillation 01/2023 - 08/2010
6	Osteoarthritis 07/2019 - 02/2009
6	Neoplasms (Cancer) 04/2019 - 12/2005
5	Deglutition Disorders (Dysphagia) 08/2023 - 01/2021
5	Wounds and Injuries (Trauma) 01/2022 - 07/2014
5	Radiculopathy (Radiculopathy, Cervical) 06/2021 - 11/2003
5	Arthritis (Polyarthritis) 02/2019 - 09/2009
4	Carcinogenesis 01/2019 - 04/2008
3	Osteoporotic Fractures 03/2024 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2023 - 01/2019
3	Infections 01/2023 - 08/2005
3	Dyslipidemias (Dyslipidemia) 10/2022 - 01/2016
3	Bone Diseases (Bone Disease) 04/2022 - 01/2011
3	Infarction (Infarctions) 01/2022 - 12/2009
3	Ischemia 01/2022 - 01/2008
3	Body Weight (Weight, Body) 01/2020 - 08/2018
3	Esophageal Squamous Cell Carcinoma 03/2016 - 02/2012
3	Pathologic Constriction (Stenosis) 01/2016 - 06/2004
3	Major Depressive Disorder (Major Depressive Disorders) 01/2014 - 01/2013
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2023 - 10/2022
2	Cerebral Infarction 06/2022 - 10/2008
2	Atherosclerotic Plaque (Atheroma) 06/2022 - 05/2014
2	COVID-19 01/2022 - 05/2021
2	Atrophy 01/2022 - 01/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2021 - 04/2011
2	Hemorrhage 05/2021 - 01/2021
2	Myocardial Infarction 05/2021 - 01/2021
2	Thromboembolism 01/2021 - 07/2013
2	Thrombosis (Thrombus) 01/2020 - 10/2009
2	Rheumatoid Arthritis 02/2019 - 03/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2019 - 03/2018
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2018 - 04/2015
2	Fibrosis (Cirrhosis) 01/2018 - 06/2011
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 12/2016

Drug/Important Bio-Agent (IBA)

10	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2022 - 05/2009
9	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2008
9	Proteins (Proteins, Gene)FDA Link 08/2023 - 04/2008
6	Therapeutic UsesIBA 05/2023 - 02/2009
5	qisheIBA 01/2022 - 01/2010
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 10/2008
4	C-Reactive ProteinIBA 11/2023 - 03/2012
4	CytokinesIBA 11/2023 - 06/2010
4	AntioxidantsIBA 05/2023 - 03/2020
4	oxidized low density lipoproteinIBA 01/2023 - 01/2016
4	LDL CholesterolIBA 01/2023 - 01/2016
4	LipidsIBA 01/2023 - 01/2016
4	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 08/2010
4	musconeIBA 01/2020 - 06/2010
4	Plant ExtractsIBA 07/2014 - 01/2010
4	Huang QiIBA 10/2013 - 01/2010
3	CalciumIBA 03/2024 - 01/2019
3	InflammasomesIBA 09/2023 - 01/2022
3	Neuroprotective AgentsIBA 09/2023 - 11/2019
3	HomocysteineIBA 06/2023 - 12/2008
3	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2016
3	AnticoagulantsIBA 01/2021 - 07/2013
3	CateninsIBA 07/2019 - 11/2013
3	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 03/2012
3	Heparin (Liquaemin)FDA LinkGeneric 05/2013 - 12/2005
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 11/2023
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2023 - 07/2010
2	Interleukin-17 (Interleukin 17)IBA 09/2023 - 01/2023
2	GinsenosidesIBA 09/2023 - 01/2022
2	omega-Chloroacetophenone (Mace)IBA 09/2023 - 01/2023
2	MelatoninIBA 05/2023 - 02/2016
2	tetramethylpyrazineIBA 04/2023 - 01/2014
2	Vitamin D FDA LinkGeneric 01/2022 - 11/2019
2	CreatinineIBA 01/2022 - 05/2021
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022 - 01/2017
2	danaparoid (Orgaran)FDA Link 01/2022 - 06/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2021 - 03/2016
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2021 - 09/2019
2	AlbuminsIBA 01/2021 - 05/2012
2	Vitamin K FDA Link 01/2021 - 07/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2016
2	Sucrose (Saccharose)IBA 01/2020 - 01/2019
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020 - 08/2015
2	Blood Glucose (Blood Sugar)IBA 09/2019 - 06/2015
2	Methotrexate (Mexate)FDA LinkGeneric 02/2019 - 03/2018
2	benazepril (Briem)FDA LinkGeneric 08/2018 - 03/2012
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 03/2004
2	Long Noncoding RNAIBA 01/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2009

Therapy/Procedure

28	Therapeutics 03/2024 - 06/2004
8	Secondary Prevention 11/2023 - 10/2008
8	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 03/2005
4	Length of Stay 08/2023 - 05/2012
3	Thrombolytic Therapy 10/2019 - 05/2009
2	Stroke Rehabilitation 05/2021 - 09/2011